Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131902) titled 'Retrospective and Prospective Single-Arm Study Analysis of Stapokibart in the Treatment of Pemphigoid' on Sept. 7.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Guangdong Provincial Hospital of Chinese Medicine (Guangdong Provincial Academic of Chinese Medicine Science; Second Clinical Medical College, Guangzhou University of Traditional Chinese Medicine)
Condition:
Pemphigoid is a group of common autoimmune blistering diseases that predominantly affects the elderly. It is characterized by tense subepidermal blisters accompanied by pruritus and urticarial erythema.
Recruitment...